Finance
Barclays slashes sales forecasts for Novo's CagriSema by more than 80%
By Maggie Fick LONDON, Feb 24 (Reuters) - Barclays analysts on Tuesday slashed their peak sales fore...
24th February, 2026
Biotech
Latest articles
Finance
Instant View: Novo's CagriSema setback may shift investor focus to M&A strategy, analysts say
Feb 23 (Reuters) - Novo Nordisk's next-generation weight-loss drug CagriSema was less effective than...
23rd February, 2026
Finance
Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly
COPENHAGEN, Feb 23 (Reuters) - Novo Nordisk said on Monday its experimental obesity drug CagriSema d...
23rd February, 2026
Finance
Biotech Inventiva's 50% surge shows investor optimism over liver disease drug
By Danilo Masoni MILAN, Jan 28 (Reuters) - A surge in Inventiva shares, up about 50% in the first fe...
28th January, 2026
Finance
Abivax CEO dismisses 'noise' around rumored Eli Lilly bid
By Sabrina Valle NEW YORK, Jan 20 (Reuters) - Abivax Chief Executive Marc de Garidel dismissed as "n...
20th January, 2026
Finance
France has had no request for investment approval in biotech Abivax - official
PARIS, Jan 12 (Reuters) - France's finance ministry has received no request seeking investment appro...
12th January, 2026
Finance
France denies contact with Eli Lilly over reported $17.5 billion Abivax deal
Jan 12 (Reuters) - Shares in Abivax soared 23%, exceeding 121 euros, on Monday after a media report...
12th January, 2026
Headlines
South Korea's ADEL signs up to $1.04 billion Alzheimer's drug development deal with Sanofi
Dec 16 (Reuters) - South Korea-based ADEL said late on Monday that it has entered a $1.04 billion pa...
16th December, 2025
Headlines
Pfizer completes up to $10 billion acquisition of Metsera
(Reuters) -Metsera shareholders on Thursday approved Pfizer's takeover offer worth up to $10 billion...
13th November, 2025
Finance
BioNTech lifts 2025 revenue guidance on BMS partnership payment
FRANKFURT (Reuters) -Germany's BioNTech on Monday lifted its 2025 revenue guidance after receiving i...
3rd November, 2025
Headlines
Novartis CEO defends $12 billion deal for Avidity as 'appropriate risk to take'
LONDON (Reuters) -Shares of Novartis fell 1% on Monday following news of the company's plans to acqu...
27th October, 2025
Headlines
Genmab to buy Dutch cancer drugmaker Merus for $8 billion
OSLO (Reuters) -Denmark's Genmab has agreed to acquire Merus NV, a Nasdaq-listed Dutch biotech firm...
29th September, 2025